development and validation of cerebrospinal fluid & blood biomarkers for neurodegenerative diseases
Published 1 year ago • 180 plays • Length 18:36Download video MP4
Download video MP3
Similar videos
-
3:35:15
pharmacodynamic biomarkers for biosimilar development and approval: day 1
-
3:42:11
pharmacodynamic biomarkers for biosimilar development and approval: day 2
-
1:42
blood and csf biomarkers for alzheimer’s disease
-
22:20
neurofilament light chain in neurodegenerative diseases – status update
-
4:07:59
translational science in drug development: surrogate endpoints, biomarkers, and more - day 2
-
56:06
biomarkers of neuroinflammation in parkinson’s disease - full video
-
1:06
cerebrospinal fluid (csf) and imaging biomarkers for the differential diagnosis of dementia
-
56:06
biomarkers of neuroinflammation in parkinson’s disease
-
1:18:56
blood biomarkers for neurodegenerative diseases
-
1:07:18
csf biomarkers: aid in the differential diagnosisof alzheimer’s disease
-
17:54
fontan associated liver disease - robert s. venick, md | 2019 nffs symposium
-
![[michael adachi] ultrasensitive detection of biofluid biomarkers associated w/alzheimer's disease](https://i.ytimg.com/vi/UNpiBuoxsNA/mqdefault.jpg)
1:01:36
[michael adachi] ultrasensitive detection of biofluid biomarkers associated w/alzheimer's disease
-
1:18:56
blood biomarkers for neurodegenerative diseases
-
2:41
csf biomarkers for the early diagnosis of alzheimer’s disease
-
16:21
oht/olt/mcs evaluation process - arnold s. baas, md | 2019 nffs symposium
-
27:21
alzheimer’s disease diagnosis and plasma phospho-tau217 - the adapt study- dr ashvini keshavan (ucl)
-
15:01
duke han: neuroepidemiology of decision making
-
1:16:12
ninth annual fall symposium